Effects of Novel E-cigarette Constituents on Adults TCORS 3.0
Public ClinicalTrials.gov record NCT05932745. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Examining Appeal and Addiction Potential of Novel E-cigarette Constituents Among Adults
Study identification
- NCT ID
- NCT05932745
- Recruitment status
- Recruiting
- Study type
- Interventional
- Phase
- Not applicable
- Lead sponsor
- Yale University
- Other
- Enrollment
- 66 participants
Conditions and interventions
Conditions
Interventions
- E-liquid coolant (4% WS-23) for high (2.0%) menthol (6) Other
- E-liquid coolant (4% WS-23) for low (0.1%) menthol (6) Other
- E-liquid coolant (4% WS-23) for non-menthol (6) Other
- E-liquid coolant (High [2.0%] WS-23) for high (2.0%) menthol (5) Other
- E-liquid coolant (High [2.0%] WS-23) for low (0.1%) menthol (5) Other
- E-liquid coolant (High [2.0%] WS-23) for non-menthol (5) Other
- E-liquid coolant (High [2.0%] WS-3) for high (2.0%) menthol (3) Other
- E-liquid coolant (High [2.0%] WS-3) for low (0.1%) menthol (3) Other
- E-liquid coolant (High [2.0%] WS-3) for non-menthol (3) Other
- E-liquid coolant (Low [0.1%] WS-23) for high (2.0%) menthol (4) Other
- E-liquid coolant (Low [0.1%] WS-23) for low (0.1%) menthol (4) Other
- E-liquid coolant (Low [0.1%] WS-23) for non-menthol (4) Other
- E-liquid coolant (Low [0.1%] WS-3) for high (2.0%) menthol (2) Other
- E-liquid coolant (Low [0.1%] WS-3) for low (0.1%) menthol (2) Other
- E-liquid coolant (Low [0.1%] WS-3) for non-menthol (2) Other
- E-liquid coolant (No WS-3) for high (2.0%) menthol (1) Other
- E-liquid coolant (No WS-3) for low (0.1%) menthol (1) Other
- E-liquid coolant (No WS-3) for non-menthol (1) Other
Other
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jun 19, 2025
- Primary completion
- Apr 30, 2026
- Completion
- Apr 30, 2026
- Last update posted
- Dec 25, 2025
2025 – 2026
United States locations
- U.S. sites
- 1
- U.S. states
- 1
- U.S. cities
- 1
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| JB Pierce Lab | New Haven | Connecticut | 06519 | Recruiting |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT05932745, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Dec 25, 2025 · Synced May 18, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT05932745 live on ClinicalTrials.gov.